UB Paderborn / Katalog / Suche / in CDI

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Annals of oncology, 2015-06, Vol.26 (6), p.1175-1179

2015

Link zum Volltext

Verfügbarkeit prüfen

Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)

Annals of oncology, 2015-05, Vol.26 (5), p.966-973

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.66-72

2014

Link zum Volltext

Verfügbarkeit prüfen

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Annals of oncology, 2016-07, Vol.27 (7), p.1317-1323

2016

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

Annals of oncology, 2016-05, Vol.27 (5), p.895-901

2016

Link zum Volltext

Verfügbarkeit prüfen

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH AGGRESSIVE NATURAL KILLER CELL LEUKEMIA: A NATIONWIDE MULTICENTER ANALYSIS IN JAPAN

Hematological oncology, 2019-06, Vol.37 (S2), p.479-480

2019

Link zum Volltext

Verfügbarkeit prüfen

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA PATIENTS RELAPSING AFTER HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION: DATA FROM THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION (JSHCT) REGISTRY

Hematological oncology, 2019-06, Vol.37 (S2), p.266-266

2019

Link zum Volltext

Verfügbarkeit prüfen

Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan

Annals of oncology, 2012-04, Vol.23 (4), p.1061-1066

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas

Leukemia, 2012-01, Vol.26 (1), p.166-169

2012

Link zum Volltext

Verfügbarkeit prüfen

PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE

Hematological oncology, 2017-06, Vol.35 (S2), p.249-250

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas.(CORRIGENDA)(Correction notice)

Leukemia, 2013-08, Vol.27 (8), p.1792

2013

Link zum Volltext

Verfügbarkeit prüfen

Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Blood cancer journal (New York), 2013-11, Vol.3 (11), p.e159-e159

2013

Link zum Volltext

Verfügbarkeit prüfen

IMMUNOTHERAPY ALONE VERSUS CHEMOIMMUNOTHERAPY AS FIRST‐LINE TREATMENT OF MARGINAL ZONE LYMPHOMA (MZL): A REAL‐WORLD ANALYSIS

Hematological oncology, 2023-06, Vol.41 (S2), p.107-108

2023

Link zum Volltext

Verfügbarkeit prüfen

Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment

Blood cancer journal (New York), 2014-08, Vol.4 (8), p.e235-e235

2014

Link zum Volltext

Verfügbarkeit prüfen

Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung

International journal of radiation oncology, biology, physics, 2023-10, Vol.117 (2), p.e492-e492

2023

Link zum Volltext

Verfügbarkeit prüfen

Real‐world treatment patterns and clinical outcomes among follicular lymphoma patients in the SEER‐Medicare population

Hematological oncology, 2023-06, Vol.41 (S2), p.372-373

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (aR2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma

Hematological oncology, 2023-06, Vol.41 (S2), p.383-383

2023

Link zum Volltext

Verfügbarkeit prüfen

A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice

Genes, brain and behavior, 2006-02, Vol.5 (1), p.19-28

2006

Link zum Volltext

Verfügbarkeit prüfen

SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL

Hematological oncology, 2023-06, Vol.41 (S2), p.837-838

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

Clinical lymphoma, myeloma and leukemia, 2022-11, Vol.22 (11), p.e1009-e1018

2022

Link zum Volltext

Verfügbarkeit prüfen

Erratum: Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas

Leukemia, 2013-08, Vol.27 (8), p.1792-1792

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessment of True Intraocular Pressure: The Gap Between Theory and Practical Data

Survey of ophthalmology, 2008-05, Vol.53 (3), p.203-218

Chihara, Etsuo, MD, PhD

2008

Link zum Volltext

Verfügbarkeit prüfen

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

Advances in radiation oncology, 2017-07, Vol.2 (3), p.370-380

2017

Link zum Volltext

Verfügbarkeit prüfen

First case report of sepsis caused by Mycobacterium wolinskyi in chronic myelogenous leukemia

Diagnostic microbiology and infectious disease, 2008-12, Vol.62 (4), p.433-436

2008

Link zum Volltext

Verfügbarkeit prüfen

Cytomegalovirus as an Etiologic Factor in Corneal Endotheliitis

Ophthalmology (Rochester, Minn.), 2008-02, Vol.115 (2), p.292-297.e3

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes

Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL)

Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH AGGRESSIVE NATURAL KILLER CELL LEUKEMIA: A NATIONWIDE MULTICENTER ANALYSIS IN JAPAN

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA PATIENTS RELAPSING AFTER HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION: DATA FROM THE JAPAN SOCIETY FOR HEMATOPOIETIC CELL TRANSPLANTATION (JSHCT) REGISTRY

Inverse association between soy intake and non-Hodgkin lymphoma risk among women: a case–control study in Japan

Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas

PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED OR REFRACTORY SYSTEMIC ANAPLASTIC LARGE T‐CELL LYMPHOMA (ALCL) RECEIVING BRENTUXIMAB VEDOTIN AND OUTCOME AFTER TREATMENT FAILURE

Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas.(CORRIGENDA)(Correction notice)

Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT)

IMMUNOTHERAPY ALONE VERSUS CHEMOIMMUNOTHERAPY AS FIRST‐LINE TREATMENT OF MARGINAL ZONE LYMPHOMA (MZL): A REAL‐WORLD ANALYSIS

Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment

Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung

Real‐world treatment patterns and clinical outcomes among follicular lymphoma patients in the SEER‐Medicare population

A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (aR2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma

A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice

SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL

Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials

Erratum: Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas

Assessment of True Intraocular Pressure: The Gap Between Theory and Practical Data

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

First case report of sepsis caused by Mycobacterium wolinskyi in chronic myelogenous leukemia

Cytomegalovirus as an Etiologic Factor in Corneal Endotheliitis

Suchergebnisse filtern